HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junko Igaki Selected Research

Reverse Triiodothyronine

11/2022Advantages of monitoring rT3 and dividing LT3 dose in the treatment of consumptive hypothyroidism associated with infantile hepatic hemangioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Junko Igaki Research Topics

Disease

2Neoplasms (Cancer)
11/2022 - 01/2018
1Hemangioma (Angioma)
11/2022
1Hypothyroidism
11/2022
1Anemia
01/2018
1Fever (Fevers)
01/2018
1Pheochromocytoma
01/2018
1Nephrogenic Diabetes Insipidus
10/2014

Drug/Important Bio-Agent (IBA)

1Indicators and Reagents (Reagents)IBA
11/2022
1Triiodothyronine (Liothyronine)FDA LinkGeneric
11/2022
1Reverse TriiodothyronineIBA
11/2022
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
11/2022
1C-Reactive ProteinIBA
01/2018
1CatecholaminesIBA
01/2018
1Ferritins (Ferritin)IBA
01/2018
1Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
10/2014